三重阴性乳腺癌治疗选择和局限性:未来的前景
Onyinyechi Obidiro1, Gantumur Battogtokh1, Emmanuel O Akala1
1Center for Drug Research and Development, Department of Pharmaceutical Sciences, College of Pharmacy, Howard University, Washington, DC 20059, USA.
Pharmaceutics
|July 29, 2023
概括
三阴性乳腺癌 (TNBC) 是由于耐药性而具有攻击性和挑战性. 纳米技术为开发更有效的TNBC疗法提供了一个有希望的途径.
科学领域:
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
- 生物化学 生物化学
背景情况:
- 三阴性乳腺癌 (TNBC) 缺乏雌激素受体 (ER),孕激素受体 (PR) 和HER2的表达,导致生存率较差.
- 目前的TNBC治疗面临的局限性包括耐药性和非向毒性,需要新的治疗策略.
研究的目的:
- 审查三阴性乳腺癌 (TNBC) 的当前和潜在治疗方案.
- 探索纳米技术在克服TNBC治疗中的挑战中的作用.
主要方法:
- 关于TNBC特征和治疗方式的综合文献综述.
- 对TNBC的化疗,免疫疗法,向疗法和基于纳米粒子的方法的分析.
- 总结TNBC管理的未来方向和潜在解决方案.
主要成果:
- 化疗,特别是用人环素和税,是TNBC的主要治疗方法,但面临耐药性和毒性问题.
- 纳米技术提供了一个潜在的解决方案,以提高药物输送和疗效,同时最大限度地减少TNBC治疗中的副作用.
- 组合疗法和新兴策略显示出改善TNBC患者治疗结果的希望.
结论:
- 有效治疗TNBC需要采取多学科的方法,解决其分子多样性和攻击性.
- 基于纳米粒子的疗法通过改善药物向性和降低毒性,具有促进TNBC治疗的巨大潜力.
- 持续的研究和合作对于开发下一代三阴性乳腺癌治疗方法至关重要.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Tumor Immunotherapy
558
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
558


